NYU Langone cardiologists share leading research at AHA Scientific Sessions 2025 & Dr. Judith S. Hochman honored with research achievement award
Meeting Announcement
Updates every hour. Last Updated: 15-Jan-2026 07:11 ET (15-Jan-2026 12:11 GMT/UTC)
Development in artificial intelligence has paved the path for the integration of computational pathology in clinical workflow, improving the accuracy and reducing the workload for medical practitioners. In recent times, Foundation Models (FMs), trained on large-scale, unlabelled datasets, are considered more suitable than traditional models for diverse clinical tasks. In a review study published in the Chinese Medical Journal, researchers highlight the advancements in pathological FMs and discuss their application in precision oncology.
Sir2, an enzyme belonging to sirtuins, has been effectively involved in the deacetylation of proteins. A tandem allosteric effect of reactant and product is responsible for the efficient deacetylation cycle of the Sir2 enzyme, reveal researchers from Science Tokyo. This finding reveals a new target for modulating Sir2, an enzyme that is essential for many biological processes, including aging, metabolic regulation, and cancer suppression. This finding could potentially lead to new therapeutic applications, including novel cancer treatments.
Space-occupying cyst (SOC), a fluid-filled sac that grows in a confined area of the body, is one of the major complications associated with brain tumor resection. Understanding the clinical features and management principles for such cysts can help patients to experience a favorable prognosis. In a recent Chinese Neurosurgical Journal Study, researchers analyzed and explored the potential characteristics and treatment strategies associated with this lesion.
A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate the same immune response as mRNA delivered by standard nanoparticles, but at around 1/100 the dose.
According to “Global Cancer Statistics- 2022”, colorectal cancer (CRC) ranks third in incidence and second in cancer-related mortality. Given that approximately 50% of cases progress to metastasis and have an unfavorable prognostic rate, CRC represents a significant health and economic burden.